New Zealand markets closed
  • NZX 50

    10,753.16
    -115.54 (-1.06%)
     
  • NZD/USD

    0.6172
    -0.0072 (-1.16%)
     
  • NZD/EUR

    0.5935
    -0.0018 (-0.30%)
     
  • ALL ORDS

    6,720.40
    -26.10 (-0.39%)
     
  • ASX 200

    6,539.90
    -28.20 (-0.43%)
     
  • OIL

    107.79
    +2.03 (+1.92%)
     
  • GOLD

    1,800.80
    -6.50 (-0.36%)
     
  • NASDAQ

    11,419.65
    -84.07 (-0.73%)
     
  • FTSE

    7,136.05
    -33.23 (-0.46%)
     
  • Dow Jones

    30,583.93
    -191.50 (-0.62%)
     
  • DAX

    12,769.72
    -14.05 (-0.11%)
     
  • Hang Seng

    21,859.79
    -137.10 (-0.62%)
     
  • NIKKEI 225

    25,935.62
    -457.42 (-1.73%)
     
  • NZD/JPY

    83.3930
    -1.3220 (-1.56%)
     

GlobalData Plc: Big Data Crucial for Business Strategy Across the Pharma Value Chain

·6-min read
GlobalData Plc
GlobalData Plc

The global data and analytics market in the pharmaceutical sector was valued at $1.4 billion in 2020

LONDON, May 18, 2022 (GLOBE NEWSWIRE) -- The healthcare and pharmaceutical industry generates data in abundance in the form of physician notes, pathology reports, EHR, patient registries, genomics, clinical trials, spontaneous adverse drug reaction reports, social media, wearable devices, and many other sources that are collected digitally. The datasets in question are huge in both size and complexity, rendering traditional data management techniques inefficient for processing. When properly analyzed, big data can be very powerful in providing insights for business strategy throughout the pharma value chain, including in the acceleration of drug discovery and development, the optimization of manufacturing processes, the management of supply chains, and the creation of innovative sales and marketing strategies.

The Big Data in Pharmaceuticals – Thematic Research report offered by GlobalData Plc assesses how big data analytics, combined with other emerging technologies, can be used across the pharma value chain. It provides an overview of the current landscape, including healthcare, technology, regulatory, and macroeconomic trends, as well as key players, while also highlighting opportunities for the use of big data analytics in the future. Moreover, the report provides an analysis of big data-related deals, jobs, and social media activity, highlighting the impact of the COVID-19 pandemic, where relevant.

For more insights on the report, download a free report sample

Key Healthcare Trends Impacting the Big Data Theme in Pharmaceuticals

  • Importance of real-world data

  • The COVID-19 pandemic

  • Clinical trial design and recruitment

  • Increased use of digital technologies in clinical research

  • Use Of AI and big data in drug discovery, drug repurposing, and vaccine development

  • Precision and personalized medicine

  • Industry 4.0

  • Wearables and the collection of health data

  • Sales and marketing

Key Technology Trends Impacting the Big Data Theme in Pharmaceuticals

  • Big data and AI will continue to dominate as transformational forces in the pharma industry

  • Cloud computing

  • 5G

  • Cybersecurity

Key Regulatory Trends Impacting the Big Data Theme in Pharmaceuticals

  • Data Privacy and regulatory compliance

  • Cures 2.0

  • Partnering with regulatory agencies

Key Macroeconomic Trends Impacting the Big Data Theme in Pharmaceuticals

  • Cost and rising healthcare demand

  • Drug pricing

  • The future of work

For more insights on trends impacting the big data theme in the pharmaceuticals industry, download a free report sample

Value Chains of Big Data in the Pharmaceuticals Market

  • Big Data Generation

  • Big Data Management

  • Big Data Product Development

To know more about the value chains of big data in the pharmaceuticals market, download a free report sample

Leading Public Big Data Vendors

  • Amazon

  • International Business Machines

  • Microsoft

  • Oracle

  • SAP SE

Leading Private Big Data Vendors

  • Antidote Technologies

  • BenevolentAI

  • Deep Genomics

  • Deep Lens

  • Exscientia

  • Healx

  • Insilico Medicine

  • Lantern Pharma

  • Medidata Solutions

  • Owkin

  • Recursion Pharmaceuticals

  • Sensyne Health

  • Syapse

  • Syneos Health

  • TriNetX

  • Unlearn.AI

Leading Big Data Adopters in the Pharmaceuticals Industry

  • Amgen

  • AstraZeneca

  • Bayer

  • Boehringer Ingelheim

  • Bristol Myers Squibb

  • Eli Lilly

  • GlaxoSmithKline Plc

  • Johnson & Johnson

  • Merck & Co

  • Moderna

  • Novartis

  • Pfizer

  • Roche

  • Sanofi

  • Takeda

  • Teva

To know more about vendors and adopters of big data in the pharmaceuticals market, download a free report sample

Big Data in Pharmaceuticals Market Overview

Market Size (2020)

$1.4 billion

Forecast Period

2021-2025

Key Trends

Healthcare Trends, Technology Trends, Regulatory Trends, and Macroeconomic Trends

Value Chains

Big Data Generation, Big Data Management, and Big Data Product Development

Leading Public Big Data Vendors

Amazon, International Business Machines, Microsoft, Oracle, and SAP SE

Leading Private Big Data Vendors

Antidote Technologies, BenevolentAI, Deep Genomics, Deep Lens, Exscientia, Healx, Insilico Medicine, Lantern Pharma, Medidata Solutions, Owkin, Recursion Pharmaceuticals, Sensyne Health, Syapse, Syneos Health, TriNetX, and Unlearn.AI

Leading Adopters of Big Data

Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co, Moderna, Novartis, Pfizer, Roche, Sanofi, Takeda, and Tevaz

Big Data in Pharmaceuticals Market Report Scope

  • Overview of the current and future use cases of big data analytics in the pharma industry, across the value chain.

  • Insightful review of the healthcare, technology, regulatory, and macroeconomic trends. Each trend is independently researched to provide a qualitative analysis of its implications in the big data space.

  • Reports of the revenue opportunity forecast in the data and analytical markets in the pharma industry from 2020 to 2025, spanning three technology segments and 49 geographical markets.

  • Key players in the big data space, with a focus on technology providers and pharma adopters.

  • Industry analysis of big data in the context of jobs in the pharma industry, use of real-world evidence in post-marketing studies, social media, and several pharma-specific case studies.

  • Deals analysis: outline of key deals within the big data space over the past three years, including mergers and acquisitions, strategic partnerships, and funding.

Reasons to Buy

  • Assess who the leading technology players are in the big data space, as well as leading pharma adopters.

  • See examples of how pharma companies are integrating big data analytics into their value chains.

  • Understand what trends are driving the big data space and challenges that exist for pharma in the space.

  • See how the big data landscape is evolving, with a review of company activity including mergers and acquisitions (M&A), strategic partnerships, and funding deals, as well as job analysis.

  • Assess the impact of COVID-19 on big data analytics.

FAQs

What was the global data and analytics market size in the pharmaceutical sector in 2020?
The global data and analytics market in the pharmaceutical sector was valued at $1.4 billion in 2020.

What are the key trends impacting the big data theme in the pharmaceuticals sector?
The key trends impacting the big data theme in the pharmaceuticals sector are healthcare trends, technological trends, regulatory trends, and macroeconomic trends.

What are the big data value chains in the pharmaceuticals market?
The big data value chains in the pharmaceuticals market are big data generation, big data management, and big data product development.

Who are the leading public big data vendors in the pharmaceuticals market?
The public big data vendors in the pharmaceuticals market are Amazon, International Business Machines, Microsoft, Oracle, and SAP SE.

Who are the leading private big data vendors in the pharmaceuticals market?
The private big data vendors in the pharmaceuticals market are Antidote Technologies, BenevolentAI, Deep Genomics, Deep Lens, Exscientia, Healx, Insilico Medicine, Lantern Pharma, Medidata Solutions, Owkin, Recursion Pharmaceuticals, Sensyne Health, Syapse, Syneos Health, TriNetX, and Unlearn.AI.

Who are the leading adopters of big data in the pharmaceuticals market?
The key adopters of big data in the pharmaceuticals market are Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co, Moderna, Novartis, Pfizer, Roche, Sanofi, Takeda, and Tevaz.

Related reports

  • Big Data in Insurance – Thematic Research - Click here

  • Big Data in Defense – Thematic Research - Click here

  • Big Data in Banking – Thematic Research - Click here

  • Big Data in Utilities – Thematic Research - Click here

  • Big Data in Oil & Gas – Thematic Research - Click here

About us

GlobalData is a leading provider of data, analytics, and insights on the world's largest industries. In an increasingly fast-moving, complex, and uncertain world, it has never been harder for organizations and decision makers to predict and navigate the future. This is why GlobalData's mission is to help our clients to decode the future and profit from faster, more informed decisions. As a leading information services company, thousands of clients rely on GlobalData for trusted, timely, and actionable intelligence. Our solutions are designed to provide a daily edge to professionals within corporations, financial institutions, professional services, and government agencies.

Media Contacts

GlobalData

Mark Jephcott
Head of PR EMEA
mark.jephcott@globaldata.com
cc: pr@globaldata.com

+44 (0)207 936 6400


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting